Understand the source comparison
Best Research Peptides for Alopecia Areata: Evidence Comparison
TB-500 (Thymosin Beta-4) Upregulates Tregs; reduces CD8+ T-cell infiltration; promotes actin-mediated tissue repair Subcutaneous injection, 2–5mg twice weekly 60% reduction in CD8+ infiltration (animal model); anagen follicle restoration in 12 weeks (JID 2021)
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- TB-500 (Thymosin Beta-4)
- Upregulates Tregs; reduces CD8+ T-cell infiltration; promotes actin-mediated tissue repair
- Subcutaneous injection, 2–5mg twice weekly
- 60% reduction in CD8+ infiltration (animal model); anagen follicle restoration in 12 weeks (JID 2021)
- Well-tolerated; mild injection site reactions; no systemic immunosuppression
- Research peptide suppliers
- GHK-Cu (Copper Peptide)
- Stimulates VEGF and dermal papilla angiogenesis; increases follicle oxygenation
- Topical gel, 0.5–1.0% concentration, twice daily
- 45% visible regrowth in 16 weeks (pilot trial, 2019); improved vascular density on dermoscopy
- Minimal adverse events; copper staining on fabrics; rare contact dermatitis
- Widely available in research formulations
- PTD-DBM (NKG2D Blocker)
- Blocks NKG2D ligand recognition; prevents T-cell-mediated keratinocyte apoptosis
- Subcutaneous injection, 300mcg monthly
- 38% achieved >90% scalp coverage; 62% >50% regrowth (Phase IIa, 2024)
- Mild injection site reactions; no systemic immune suppression
- Investigational only (clinical trials)